Asthma as a Comorbid Disease in COVID-19

Creative Commons License

BAÇÇIOĞLU A., BAVBEK S.

ASTIM ALLERJI IMMUNOLOJI, cilt.18, ss.1-7, 2020 (ESCI) identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 18
  • Basım Tarihi: 2020
  • Doi Numarası: 10.21911/aai.565
  • Dergi Adı: ASTIM ALLERJI IMMUNOLOJI
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.1-7
  • Anahtar Kelimeler: Asthma, severe asthma, asthma attack, viral infection, coronavirus disease 2019, COVID-19, SARS-CoV-2
  • Ankara Üniversitesi Adresli: Evet

Özet

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel coronavirus that causes coronavirus disease 2019 (COVID-19). In terms of asthma and COVID-19, there is also a risk of experiencing an asthma exacerbation triggered by coronavirus infection beyond the direct risk of the infection itself. As a comorbid disease, the prevalence of COVID-19 infection in asthma patients is not clear. In addition, the influence of asthma on the severity of COVID-19 has not been reported. The aim of this review was to summarize the reported worldwide data about the prevalence and the clinical characteristics of patients with asthma during COVID-19 infection.